Loumeau Eric J's Form 4 filing
Anaptysbio, Inc (ANAB) · filed Jan 9, 2026
- Accession no.
- 0001239648-26-000006
- Filed
- Jan 9, 2026
- Trade date
- Jan 7-8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $98.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Loumeau Eric JCIK 0001239648 | Officer (CHIEF LEGAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Common Stock | MOption exerciseAcquired | +5,888 | – | – | 15,045 | Direct | |
| Jan 8, 2026 | Common Stock | SSaleDisposed | −2,210 | $44.71 | −$98,809.1 | 12,835 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Common Stock | MOption exerciseDisposed | −5,888 | $0.00 | $0 | 17,662 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.